Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease by Lopes, Maria Luiza Diniz de Sousa et al.
CASE REPORT
Severe maxillofacial renal osteodystrophy in two patients
with chronic kidney disease
Maria Luiza Diniz de Sousa Lopes1 & Assis Filipe Medeiros Albuquerque2 &
Adriano Rocha Germano2 & Lélia Maria Guedes Queiroz1 &
Márcia Cristina da Costa Miguel1 & Éricka Janine Dantas da Silveira1
Received: 7 December 2014 /Accepted: 9 March 2015 /Published online: 19 March 2015
# Springer-Verlag Berlin Heidelberg 2015
Abstract Renal osteodystrophy (ROD) is the bone pathology
that occurs as an uncommon complication related to the several
alterations inmineralmetabolism present in patientswith chronic
kidney disease (CKD). This paper describes two cases of severe
ROD affecting the maxilla and mandible and causing facial dis-
figurement of a young and a middle-aged female patient with
CKD. Both patients had a history of secondary hyperparathy-
roidism, previously treated by surgery. The pathogenesis of the
disease, as well as its clinical, imaging, and histopathological
features, and management of the patient are discussed.
Keywords Renal osteodystrophy . Chronic kidney disease .
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Introduction
Chronic kidney disease (CKD) is the progressive and irrevers-
ible loss of renal function, usually leading to end-stage renal
disease, a potentially fatal condition, requiring chronic hemo-
dialysis or kidney transplantation for survival [1, 2]. One of
the complications that can arise in patients with CKD is the
clinical syndrome chronic kidney disease-mineral and bone
disorder (CKD-MBD), which involves changes in laboratory
tests such as serum calcium, organic phosphate, parathyroid
hormone (PTH), and concentrations of vitamin D derivatives;
changes in bone turnover; and extraskeletal calcifications [3,
4]. Renal osteodystrophy (ROD) has recently been redefined
to refer to the bone pathology from this syndrome [5].
Advancements in the knowledge about CKD and its com-
plications, such as secondary hyperparathyroidism (HPT-II)
and ROD, resulted in a decreased frequency of significant
macroscopic bone alterations in kidney patients.
Nonetheless, radiographic changes of the facial skeleton still
eventually occur, occasionally involving the jaws, and may
represent an early sign of ROD [6–8]. This manuscript reports
the details of two unusually severe maxillofacial manifesta-
tions of ROD in patients with CKD, emphasizing the
laboratorial, clinical, imaging, and histological features as
well as patient management.
Case reports
Patient 1
A 23-year-old female was referred to the Oral and
Maxillofacial Surgery Service of our department with a 4-
year history of an asymptomatic, expansive mass in the right
side of the face causing airway compromise and facial disfig-
urement (Fig. 1a). On intraoral examination, there were mac-
roscopic enlargement of the right maxilla and a less severe
increase in volume of the right mandible (Fig. 1b). In addition,
the patient presented gingivitis, carious teeth, and malocclu-
sion. She had a history of idiopathic CKD in advanced stage
and had been receiving hemodialysis three times a week for
10 years, while on a kidney transplant waiting list. During this
period, she developed HPT-II reaching 1452 pg/mL as a
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maximum level of PTH. The treatment was a total parathy-
roidectomy combined with partial autotransplantation in the
forearm. Subsequently, she reported that the facial lesion size
stabilized. Her current medication included folic acid, B vita-
mins, prednisone, Renagel, and calcium carbonate. The pan-
oramic radiography demonstrated a prominent ill-defined ra-
diopaque area in the maxilla affecting the maxillary sinus and
a mixed radiolucency-radiopacity in the mandible. Both areas
displayed a ground-glass appearance (Fig. 2a). The clinical
diagnosis of a brown tumor was suggested. Incisional biopsy
of the maxillary affected area was performed under local an-
esthesia, and microscopic examination showed interconnected
and irregularly shaped trabeculae of woven bone interspersed
with loose connective tissue with sparse fibroblasts and mod-
erate vascularization (Fig. 2b). The histopathological diagno-
sis was suggestive of renal osteodystrophy. A computed to-
mography (CT) scan and blood tests were requested in order
to plan the surgical removal of the lesion. The CT scan re-
vealed marked osseous expansion on the right side of the face,
with endophytic and exophytic growth, affecting the body of
the zygomatic bone and the entire portion of the right maxilla
(Fig. 3a). The involvement of the infraorbital floor and
invasion of the nasal cavity were observed, which resulted in
nasal and ophthalmic functional commitment, respectively. A
lateral radiograph of the thoracic spine showed an intact bone
structure (Fig. 3b), and there was no reported involvement of
the limbs. Abdominal, cardiovascular, and pulmonary exami-
nations were unremarkable. Laboratorial findings, 3 days be-
fore the surgical procedure, showed a red blood cell count of
5.7 cells/mm3 (normal range 4–5.2 cells/mm3), leukocyte
count of 6.400/μL (normal 3.500–10.000/μL), platelet count
of 104.000/mm3 (normal 150.000–450.000/mm3), hematocrit
of 45.2 % (normal range for women 35–46 %), serum creat-
inine of 11.19 mg/dL (normal 0.53–1.2 mg/dL), serum calci-
um of 7.01 mg/dL (normal 8.8–11 mg/dL), serum phosphate
of 4.72 mg/dL (normal range 2.5–4.8 mg/dL), alkaline phos-
phatase level of 89 international units (IU)/L (normal range
27–100 IU/L), and serum PTH of 149 pg/mL (normal 10–
65 pg/mL). The patient was submitted to surgical removal of
the lesion at the hospital under general anesthesia with
orotracheal intubation. One day prior to the procedure, the
patient underwent hemodialysis, and due to the CKD status
and thrombocytopenia, a hemodynamic preparation was con-
ducted preoperatively and in the immediate postoperative
Fig. 1 Extraoral view showing a
severe swelling associated with
facial asymmetry and deletion of
the right nasolabial fold (a).
Intraoral view showing the well-
circumscribed enlargement in the
right maxilla causing
displacement of adjacent teeth
and a smaller swelling in the
edentulous area of the mandible
(b)
Fig. 2 Radiopaque image with imprecise limits in the anterior maxilla
involving the maxillary sinus. Mandibular lesion revealing a mix of
radiolucent and radiopaque appearance and well-defined limits (a).
Histological appearance revealing trabeculae of vital woven bone lying
in a loose connective tissue background containing few cells and
moderate vascularization (H&E) (b)
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period. Hence, the infiltration of 2 bags of platelet-rich plasma
and 10 units of cryoprecipitate was used as suggested by the
hematology service of the hospital. During surgery, a Weber-
Ferguson incision was made, followed by dissection in planes
(maintaining the integrity of the oral mucosa and attached
gingiva) to obtain a proper visualization of the lesion
(Fig. 4a). Due to the extension of the lesion far to the medial,
reaching the nasal cavity, orbital floor, hemi-maxilla, and zy-
gomatic bone, only the osteoplasty and plasty of the surround-
ing soft tissue were performed, avoiding the mutilation of the
patient and restoring the normal conformation of the face. The
lesion invading the region of the nasal cavity was removed, in
order to improve the breathing. After the procedure, the pa-
tient went to the intensive care unit and underwent hemodial-
ysis 1 day after surgery. The fragments sent for pathological
analysis revealed the same characteristics of the specimen
previously obtained from incisional biopsy. The final patho-
logic diagnosis was consistent with ROD. One year after the
surgery (Fig. 4b), the patient showed no evidence of any in-
crease of volume in the maxilla and is preparing for the
removal of the mandibular lesion, as well as for the kidney
transplant.
Patient 2
A 44-year-old woman presented an extraoral appearance of
significant swelling in the middle and lower third of the face
(Fig. 5a); thus, the clinical description of “leontiasis ossea”
was presented. On intraoral examination, a hard and asymp-
tomatic swelling in the right maxilla was evident, as well as in
the mentonian area of the mandible, both covered by normal
mucosa (Fig. 5b). The maxillary lesion was expanding the
buccal bone plate along with the hard palate. In the mandible,
significant expansion in the buccal bone plate mandible in-
volving the region between teeth 36 and 46 was observed,
changing the normal teeth arrangement. The patient
complained of difficulty breathing through the nose at night.
The patient first noted the enlargement 6 years earlier which
steadily increasing since then. Medical history showed hyper-
tension and a 10-year history of CKD for which she has been
Fig. 3 Axial CT scan showing
bone expansion consisting of
irregularly arranged bone
trabeculae with considerable
variation in density (a). Lateral
radiograph of the thoracic spine
showing no bone alterations (b)
Fig. 4 Once the lesion was
exposed during surgery, it
revealed bleeding aspect (a).
Postoperative appearance 1 year
after surgery (b)
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receiving hemodialysis three times a week. During this period,
the patient developed HPT-II, achieving a maximum value of
serum parathyroid hormone (PTH) of 1056 pg/mL (normal
10–65 pg/mL). The patient underwent total parathyroidecto-
my associated with partial autotransplantation in the forearm
1 year before being referred to our department. Her medica-
tion included losartan potassium and clonidine hydrochloride.
Panoramic radiography showed a marked expansion of the
maxilla and mandible, with a ground-glass appearance and
teeth hypercementosis (Fig. 6). There were no bone manifes-
tations at other areas of the body. Laboratory examination
showed current red blood cell count of 4.2 cells/mm3 (normal
range 4–5.2 cells/mm3), leukocyte count of 6.200/μL (normal
3.500–10.000/μL), platelet count of 325.000/mm3 (normal
150.000–450.000/mm3), hematocrit of 37.8 % (normal range
for women 35–46 %), serum creatinine of 11.17 mg/dL (nor-
mal 0.53–1.2 mg/dL), serum calcium of 6.9 mg/dL (normal
8.8–11 mg/dL), serum phosphate of 4.72 mg/dL (normal
range 2.5–4.8 mg/dL), alkaline phosphatase of 244 IU/L)
(normal range 27–100 IU/L), and serum PTH of 208 pg/mL
(normal 10–65 pg/mL). The clinical diagnostic hypothesis
was ROD and brown tumor. The patient underwent incisional
biopsies of both maxillary and mandibular lesions under local
anesthesia. Microscopic examination revealed vital and
irregular trabeculae of woven bone in different maturation
stages, occasionally showing osteoblastic rimming as well as
multinucleated osteoclast-type giant cells into a vascularized
fibrous connective tissue (Fig. 7). The clinical, biochemical,
imaging, and microscopic studies lead to a diagnosis of oste-
itis fibrosa consistent with ROD. The patient was submitted to
osteoplasty of both lesions by an intraoral approach in the
hospital under general anesthesia. Sections of the collected
specimen confirmed the histopathological diagnosis osteitis
fibrosa consistent with ROD. Ten months after the surgery,
the patient shows no noticeable bone changes on her facial
contour and is under nephrologic care (Fig. 8).
Discussion
Patients with CKD commonly have alterations in several min-
eral metabolisms including hyperphosphatemia, hypocalce-
mia, and 1,25-dihydroxyvitamin D3 or calcitrol (active metab-
olite of vitamin D), which eventually lead to a compensatory
overproduction of PTH by parathyroid glands in a condition
known as HPT-II [9–11]. As renal function declines, 1,25-
dihydroxyvitamin D3 synthesis becomes impaired, which
Fig. 5 Extraoral view (patient 2) showing a swelling in the middle and lower third of the face resembling a leonine face (a). Intraoral view of severe
maxillary and mandibular enlargement causing teeth separation (b)
Fig. 6 Panoramic radiography (patient 2) displaying marked expansion
of bone structures with ground-glass appearance and several teeth with
hypercementosis
Fig. 7 Multinucleated giant cells throughout the stroma and plump
osteoblasts adjacent to the osteoid matrix (patient 2; H&E)
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leads to deficiency in renal calcium absorption, resulting in
hypocalcemia. The calcium sensing receptor (CaSR), which is
highly expressed in the parathyroid glands, senses the low
serum calcium concentrations, leading to a compensatory in-
crease in PTH (HPT-II) in the attempt to maintain the homeo-
stasis of calcium [10]. In the meantime, the reduction of glo-
merular filtration also leads to impaired phosphate excretion,
elevating the serum concentrat ion of phosphate.
Hyperphosphatemia can act by directly stimulating PTH syn-
thesis and parathyroid hyperplasia and indirectly promoting
HPT-II by decreasing the serum calcium level [1, 2, 10].
Excess of PTH acts in the transformation of the inactive form
of vitamin D to 1,25-dihydroxyvitamin D3 in the kidney and
influences the development and activity of osteoclasts, osteo-
blasts, and osteocytes, thereby affecting bone turnover [1, 4].
Due to the mineral alterations, patients with ROD should
run basic blood tests, including electrolytes, full blood cell
count, PTH, and alkaline phosphatase levels [2]. The labora-
tory findings of both patients revealed a serum PTH level
slightly elevated, but when it is compared to the levels before
the removal of the parathyroid glands, the considerable im-
provement in the HPT-II status became evidently unmistak-
able. Especially in patient 1, this fact was supported by the
demonstrated normal levels of calcium, phosphorus, and alka-
line phosphatase, the latter being a biochemical marker and,
together with the PTH, commonly used in the diagnosis of
different forms of bone disease associated with CKD [12].
Usually, the alterations in bone metabolism are diagnosed
by laboratory tests before the development of macroscopic
skeletal changes [7, 10]. The majority of macroscopic mani-
festations of ROD present as diffuse jaw enlargement [13].
However, recently, the pattern of localized expansion was re-
ported to be more common than originally recognized [5].
Patient 1 exhibited localized enlargements of the maxilla and
mandible, causing facial disfigurement, while the bone alter-
ations of patient 2 looked more diffuse. In addition, the alter-
ations were exclusively in the jaw bones, any manifestation in
long bones and aorta being discarded.
The extreme clinical manifestation of ROD is denominated
leontiasis ossea represented by hyperostotic changes in the
facial bones and may cause an expansion of the malar process-
es, a reduced nasomaxillary angle, widening of the nares,
flattening of the nasal bridge, and an increase of interdental
space [9]. This ultimate condition results in lion-like facial
features observed in patient 2, which clinically and histologi-
cally resembles the big head disease observed in animals with
hyperparathyroidism secondary to kidney problems or to diets
rich in phosphorus and calcium deficiency [2].
Such facial disfigurement as in leontiasis ossea is an un-
common feature of ROD and is not specific because it can be
present in other lesions such as fibrous dysplasia, or Paget’s
disease of bone [9]. Craniofacial fibrous dysplasia is asym-
metric and can cause cranial neuropathies, headaches, and
occlusal discrepancies [2]. In contrast to ROD, fibrous dyspla-
sia typically occurs in childhood and accompanies a biochem-
ical profile within normal limits [5, 13]. Concerning Paget’s
disease, the rates of osteoclastic and osteoblastic activities are
elevated, resulting in skeletal remodeling and weakened de-
formed bones. However, when it affects jawbones, it is typi-
cally bilateral [14]. Moreover, even showing increased levels
of alkaline phosphatase, the serum level of calcium in Paget’s
disease is normal [2].
Some radiographic findings of ROD of the jaws also occur
in fibrous dysplasia, or Paget’s disease of bone, such as
ground-glass appearance, observed in both current patients;
hypercementosis noticed on patient 2; and bone resorption
with loss of lamina dura [13]. Some of the radiographic alter-
ations of ROD include demineralization of bone, delayed
tooth eruption, mixed osteolysis and sclerosis (salt-and-pep-
per) trabecular appearance, absence of lamina dura, thickening
of the diploic space of the calvarium, dental spacing and mo-
bility, jaw fracture, and poor definition of anatomical land-
marks [9]. The CT scan can show changes in the trabecular
pattern and bone expansion and, along with magnetic reso-
nance imaging, is helpful for diagnosis and treatment planning
[15].
Microscopic and pathologic features of ROD are dynamic
in their progression and can be subdivided into low- and high-
turnover bone diseases or with a combined pattern of the two
categories [16]. Osteitis fibrosa represents increased bone
turnover as it is associated with hyperparathyroidism, while
decreased turnover mainly characterizes osteomalacia and
adynamic (aplastic) bone disease [7, 13]. Osteitis fibrosa used
to be the most common type of ROD; however, in the last
decades, adynamic bone disease has become the most com-
mon form [17]. Microscopic findings of osteitis fibrosa reveal
prominent peritrabecular fibrosis associated with an increased
number and activity of osteoclasts associated with increased
numbers of osteoblasts and osteoid [2, 13, 18]. Those features
were present in patient 2, justifying the diagnosis of osteitis
fibrosa. On the other hand, osteomalacia is characterized by
defective mineralization and increased osteoid production
mainly caused by the decrease of 1,25-dihydroxyvitamin D3
concentrations, usually causing osseous pain and musculo-
skeletal disability and making the patient at risk of osteopenia,
Fig. 8 Facial appearance 10 months after operation (patient 2)
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bone deformity, and fracture [1, 4, 5]. Adynamic bone disease
is most frequent in CKD patients without HPT-II and is usu-
ally related to increased risk of hypercalcemia, cardiovascular
calcification, and mortality. No osteoid accumulation is
present, and there are only few or absent osteoblasts
and little or no fibrosis in either the bone marrow or
peritrabecular area [17]. The absence of osteoid deposi-
tion or osteoclastic activity in patient 1 specimens reflects
the lack of active bone metabolism, or even normal bone
metabolism, probably because the patient’s bone disease
was under control.
Differential diagnosis of ROD, besides fibrous dysplasia
and Paget’s disease of the bone, should include brown tumors
of HPT-II, which generally can be discarded by radiographic
appearance or/and histopathological examination. Brown tu-
mors are more likely to occur in primary hyperparathyroidism,
showing a radiographic appearance of a well-circumscribed
radiolucent lesion and typically revealingmultinucleated giant
cells and prominent hemosiderin deposition under light mi-
croscopy [5, 6, 8]. As observed in patient 2, the presence of
multinucleated giant cells can also occur in ROD, but accord-
ing to Lerman et al. [5], it is less prominent than brown tu-
mors. The Sagliker syndrome, recently described by Sagliker
et al. [19], also must be considered in the differential diagnosis
of ROD, since it is seen in 0.5 % of patients with CKD [20].
However, in addition to HPT-II and CKD, the diagnostic
criteria for this syndrome include short stature, extremely se-
vere maxillary and mandibular changes (uglifying the face),
soft and histopathologically verified benign epithelial hyper-
plasia, severe teeth/dental abnormalities, fingertip changes,
knee and scapula deformities, abnormalities in audition, and
severe neurological and psychological disturbances [20, 21].
Management of ROD is based on control of factors respon-
sible for the development of altered bone metabolism [22].
ROD associated with HPT-II can be improved with the cor-
rection of calcium and vitamin D levels and a decrease in
phosphate levels. This can be accomplished by conservative
treatment, such as the use of phosphate-binding agents, treat-
ment with calcitriol and other active vitamin D sterols, and
following a phosphate-restricted diet [1, 2, 9]. Despite medical
therapy, in several patients, the altered PTH levels persist,
requiring surgical intervention with total parathyroidectomy
with or without autotransplantation or subtotal parathyroidec-
tomy. The ultimate treatment for persistent HPT-II in the two
cu r r e n t p a t i e n t s wa s p a r a t hy r o i d e c t omy w i t h
autotransplantation, which involves the transplantation of a
small amount of parathyroid tissue into the forearm, aiming
to maintain normal parathyroid function. If recurrent hyper-
parathyroidism occurs, this technique allows a simple access,
with locoregional anesthesia, for removal of the fragments
from the forearm [23].
Even with the adjustment of the PTH levels, the total re-
gression of bone alterations is unusual; therefore, most cases
require surgical recontouring. There are few reports of ROD
manifestations in jaws resolved after the correction of the
HPT-II condition, without surgical intervention [24, 25]. The
jaw enlargement in the present patients ceased after the treat-
ment of HPT-II, but surgery was necessary mainly for im-
provement of breathing and for esthetics consideration.
This manuscript emphasizes the importance of a detailed
anamnesis and clinical and microscopic investigation for the
diagnosis and appropriate treatment of ROD affecting the
maxillofacial region. Even though the altered bone metabo-
lism usually is biochemically detected before patients have
any significant symptomatology, the cases reported here high-
light that in unusual circumstances it may develop into severe
bone alterations.
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